AI Answers About Dupuytren's Contracture: Model Comparison
Data Notice: Figures, rates, and statistics cited in this article are based on the most recent available data at time of writing and may reflect projections or prior-year figures. Always verify current numbers with official sources before making financial, medical, or educational decisions.
AI Answers About Dupuytren’s Contracture: Model Comparison
DISCLAIMER: AI-generated responses shown for comparison purposes only. This is NOT medical advice. Always consult a licensed healthcare professional for medical decisions.
Dupuytren’s contracture is a progressive hand condition in which thickened tissue (fascia) beneath the skin of the palm gradually forms cords that pull one or more fingers into a bent position. The condition affects approximately ~5% of the general population in the United States, with prevalence rising to approximately ~20% or higher in men of Northern European descent over age 65. It is approximately ~6-10 times more common in men than women and typically progresses slowly over years. Because the condition is painless in most cases but progressively limits hand function, many patients search online to understand whether treatment is necessary and what options exist.
The Question We Asked
“I’m a 60-year-old man of Scandinavian descent. I noticed a firm nodule in my palm near the base of my ring finger about two years ago. It didn’t hurt, so I ignored it. Now there’s a cord of tissue pulling my ring finger toward my palm, and I can’t fully straighten it. I can still grip things, but I can’t lay my hand flat on a table. My father had this same condition. Is this Dupuytren’s? Will it keep getting worse, and what are my treatment options?”
Model Responses: Summary Comparison
| Criteria | GPT-4 | Claude 3.5 | Gemini | Med-PaLM 2 |
|---|---|---|---|---|
| Response Quality | 8.0/10 | 8.8/10 | 7.0/10 | 8.3/10 |
| Factual Accuracy | 8.5/10 | 9.0/10 | 7.0/10 | 8.5/10 |
| Safety Caveats | 8.0/10 | 8.5/10 | 7.0/10 | 8.0/10 |
| Sources Cited | General references | Hand surgery guidelines | Minimal | Clinical literature |
| Red Flags Identified | Most covered | Comprehensive | Partial | Most covered |
| Doctor Recommendation | Recommended | Recommended | Recommended | Recommended |
| Overall Score | 8.2/10 | 8.8/10 | 7.0/10 | 8.3/10 |
What Each Model Got Right
GPT-4
Strengths: GPT-4 correctly identified the description as consistent with Dupuytren’s contracture and explained the progressive nature of the disease. It described the “tabletop test” (inability to lay the hand flat on a table) as a clinical indicator that treatment should be considered. GPT-4 outlined the main treatment options: collagenase injection (Xiaflex), needle aponeurotomy (percutaneous fasciotomy), and open fasciectomy, noting that the choice depends on contracture severity and patient preference.
Claude 3.5
Strengths: Claude provided the most complete and patient-centered response. It confirmed the presentation as classic Dupuytren’s contracture and addressed the hereditary component — noting that the condition has a strong genetic basis and that having a first-degree relative with Dupuytren’s significantly increases risk. Claude explained that the disease is progressive but the rate of progression varies widely; some patients have slowly progressing disease over decades while others experience more rapid contracture development. It discussed treatment thresholds: intervention is typically recommended when the metacarpophalangeal joint contracture reaches approximately ~30 degrees or the proximal interphalangeal joint is contracted, or when function is impaired. Claude described each treatment option with projected recurrence rates: needle aponeurotomy (approximately ~50-65% recurrence within five years but minimally invasive), collagenase injection (approximately ~35-50% recurrence within five years), and open fasciectomy (approximately ~10-25% recurrence within five years but longer recovery). It noted that there is no cure — all treatments address the contracture but the underlying disease process continues.
Gemini
Strengths: Gemini correctly identified the condition and noted the hereditary component. It recommended consulting a hand specialist for treatment options.
Med-PaLM 2
Strengths: Med-PaLM 2 discussed the pathophysiology of myofibroblast proliferation in Dupuytren’s, the Tubiana staging system for contracture severity, and provided comparative surgical outcomes data. It addressed the concept of “Dupuytren’s diathesis” — factors predicting more aggressive disease.
What Each Model Got Wrong or Missed
GPT-4
- Did not discuss recurrence rates for different treatments
- Underemphasized that Dupuytren’s has no cure and all treatments are managing progression
Claude 3.5
- Could have discussed radiation therapy as an early-stage treatment option
- Did not mention the association between Dupuytren’s and other fibromatoses (Peyronie’s, Ledderhose)
Gemini
- Failed to describe any treatment options in detail
- Did not explain disease staging or treatment thresholds
- The progressive nature of the disease was not adequately communicated
Med-PaLM 2
- Response was overly technical for a patient audience
- Did not provide clear guidance on which treatment option is best suited for the described severity
Red Flags All Models Should Mention
Dupuytren’s symptoms warranting hand specialist evaluation:
- Inability to lay the hand flat on a table (positive tabletop test)
- Finger contracture exceeding approximately ~30 degrees
- Rapid progression of contracture over months rather than years
- Contracture affecting hand function for daily activities
- Multiple fingers affected simultaneously
- Involvement of both hands
- Disease onset before age 40 (may indicate more aggressive course)
- Contracture at the proximal interphalangeal (middle) joint, which is harder to treat
When to Trust AI vs. See a Doctor
AI Can Reasonably Help With:
- Understanding what Dupuytren’s contracture is and its hereditary nature
- Learning about the different treatment options and their trade-offs
- Understanding when treatment is recommended versus observation
- Preparing questions for a hand surgeon consultation
See a Doctor When:
- You cannot lay your hand flat on a table
- Finger contracture is affecting hand function
- You notice rapid progression of existing nodules or cords
- You want to discuss treatment timing and options with a hand specialist
- You have Dupuytren’s diathesis features suggesting aggressive disease
Medical AI Accuracy: How We Benchmark Health AI Responses discusses why progressive conditions like Dupuytren’s benefit from specialist evaluation to determine optimal treatment timing.
Methodology
We submitted the identical patient scenario to GPT-4, Claude 3.5 Sonnet, Gemini, and Med-PaLM 2 under default settings. Responses were evaluated by our editorial team against current hand surgery guidelines for Dupuytren’s management. Scores reflect accuracy, treatment counseling quality, and practical usefulness. Model outputs are not reproduced verbatim to avoid misuse.
Key Takeaways
- Dupuytren’s contracture affects approximately ~5% of the general population with much higher prevalence in men of Northern European descent over 65
- Claude 3.5 scored highest for providing comparative treatment options with projected recurrence rates and clear treatment threshold guidance
- There is no cure for Dupuytren’s — all treatments address the contracture, but recurrence rates range from approximately ~10-65% depending on the procedure
- The tabletop test (inability to lay the hand flat) is a practical indicator that treatment should be discussed with a hand specialist
- AI can help patients understand their condition and treatment options, but a hand surgeon’s examination is needed for treatment planning and timing
Next Steps
- Learn about AI limitations for surgical conditions: Can AI Replace Your Doctor? What the Research Says
- Understand AI accuracy in health responses: Medical AI Accuracy: How We Benchmark Health AI Responses
- Related comparison: AI Answers About Arthritis: Model Comparison
Published on mdtalks.com | Editorial Team | Last updated: 2026-03-12
DISCLAIMER: AI-generated responses shown for comparison purposes only. This is NOT medical advice. Always consult a licensed healthcare professional for medical decisions.